CORRIE BERK: Open Payments
NPI 1497299184 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$73,028 in 137 payments from 7 companies in 2025. Trend: 2023 $10,345 · 2024 $43,087 · 2025 $73,028
Speaker / faculty: $44,429Travel & lodging: $20,528Consulting: $4,380Food & beverage: $3,691
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 73 | $46,406 |
| Gilead Sciences, Inc. | 34 | $17,890 |
| Ipsen Biopharmaceuticals, Inc | 10 | $3,901 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $3,537 |
| Mallinckrodt Hospital Products Inc. | 1 | $1,170 |
| Boston Scientific Corporation | 1 | $106 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
Products named: REZDIFFRA, Livdelzi, Epclusa, IQIRVO, XIFAXAN, TERLIVAZ, TheraSphere Y90 Glass Microspheres 10 GBq, OCALIVA.
Industry payments across TX — which companies pay providers there.
